A recent statement from ESHRE’s COVID-19 working group, also evident in the vaccines’ product information, notes limited data on vaccination in pregnancy and none before conception with assisted reproduction. Eligibility for COVID-19 vaccination in and before pregnancy so far rests on an individual assessment of risks and benefits.
FUNDING OF ART
Large Canadian study finds state-funded ART linked to a higher rate of SET and a lower risk of adverse neonatal outcomes for mother and baby.
ERRORS IN ART 2
A well attended Campus meeting in November heard how quality management systems and a willingness to discuss all mishaps and near-misses reduce the risks of errors in the ART clinic.
A study which cross-linked more than 30,000 Dutch ART patients to the national cancer registry with follow-up over a mean of 24 years found they had a greater risk of ovarian cancer than women in the general population but no greater risk than in an untreated group of sub-fertile women.
Large retrospective study of more than 4000 euploid embryo transfers finds very high implantation rates after each of three successive FETs. Recurrent implantation failure likely to be embryonic and not endometrial in its origin, propose investigators.
A well attended online Campus course staged by the SIG Reproductive Genetics heard that the expansion of sequencing analysis is poised to push forward the development of cost-effective preconception tests able to identify several underlying genetic causes of infertility
A well attended online Campus meeting in December heard that outcome from elective oocyte cryopreservation depends on the number of MII oocytes retrieved, and that varies with age. Older age also brings more neonatal risks for mother and baby.
ESHRE’s COVID-19 working group hosted a session at this year’s Progress Educational Trust annual meeting to reveal striking differences between clinic activity during the first infection wave and the second. A strict protocol of triage and testing can keep fertility centres COVID-free.
EUROPEAN IVF MONITORING
Twenty years after its first data collection from European ART cycles, ESHRE’s IVF Monitoring Consortium has compared its cumulative findings with two other national registries – and found that Europe is the slowest on the uptake of new techniques.
Get notified of new articles with our ESHRE newsletter.
Sign up and never miss an update